Please select the option that best describes you:

How do you approach the re-challenge with trastuzumab in metastatic HER2+ patients who develop cardiomyopathy on trastuzumab/pertuzumab with subsequent improvement with discontinuation?   

Do you repeat the loading dose of trastuzumab?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Lehigh Valley Physicians Group
Agree. I am part of the cardio-oncology at our can...
Medical Oncologist at PPG - Oncology
What is the latest you would restart? PI says perm...
Medical Oncologist at Icahn School of Medicine at Mount Sinai
I would
Sign in or Register to read more